Medical Care
Global Urea Cycle Disorders Treatment Drug Market Research Report 2025
- May 05, 25
- ID: 228165
- Pages: 87
- Figures: 82
- Views: 4
The global market for Urea Cycle Disorders Treatment Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Urea Cycle Disorders Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urea Cycle Disorders Treatment Drug.
The Urea Cycle Disorders Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Urea Cycle Disorders Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urea Cycle Disorders Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Horizon Therapeutics Plc
Bausch Health Companies Inc.
Recordati Rare Diseases Inc.
Nestle S.A.
Danone S.A.
Lucane Pharma SA
Acer Therapeutics Inc.
Ultragenyx Pharmaceutical
Aeglea Biotherapeutics, Inc
Arcturus Therapeutics Holdings Inc.
Orpharma Pty Ltd.
Selecta Biosciences, Inc.
Abbott
Mead Johnson & Company, LLC
Segment by Type
Amino Acid Supplements
Sodium Phenylbutyrate
Glycerol Phenylbutyrate
Sodium Benzoate
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Urea Cycle Disorders Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Urea Cycle Disorders Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urea Cycle Disorders Treatment Drug.
The Urea Cycle Disorders Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Urea Cycle Disorders Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urea Cycle Disorders Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Horizon Therapeutics Plc
Bausch Health Companies Inc.
Recordati Rare Diseases Inc.
Nestle S.A.
Danone S.A.
Lucane Pharma SA
Acer Therapeutics Inc.
Ultragenyx Pharmaceutical
Aeglea Biotherapeutics, Inc
Arcturus Therapeutics Holdings Inc.
Orpharma Pty Ltd.
Selecta Biosciences, Inc.
Abbott
Mead Johnson & Company, LLC
Segment by Type
Amino Acid Supplements
Sodium Phenylbutyrate
Glycerol Phenylbutyrate
Sodium Benzoate
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Urea Cycle Disorders Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Amino Acid Supplements
1.2.3 Sodium Phenylbutyrate
1.2.4 Glycerol Phenylbutyrate
1.2.5 Sodium Benzoate
1.2.6 Others
1.3 Market by Application
1.3.1 Global Urea Cycle Disorders Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Urea Cycle Disorders Treatment Drug Market Perspective (2020-2031)
2.2 Global Urea Cycle Disorders Treatment Drug Growth Trends by Region
2.2.1 Global Urea Cycle Disorders Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Urea Cycle Disorders Treatment Drug Historic Market Size by Region (2020-2025)
2.2.3 Urea Cycle Disorders Treatment Drug Forecasted Market Size by Region (2026-2031)
2.3 Urea Cycle Disorders Treatment Drug Market Dynamics
2.3.1 Urea Cycle Disorders Treatment Drug Industry Trends
2.3.2 Urea Cycle Disorders Treatment Drug Market Drivers
2.3.3 Urea Cycle Disorders Treatment Drug Market Challenges
2.3.4 Urea Cycle Disorders Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Urea Cycle Disorders Treatment Drug Players by Revenue
3.1.1 Global Top Urea Cycle Disorders Treatment Drug Players by Revenue (2020-2025)
3.1.2 Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Players (2020-2025)
3.2 Global Urea Cycle Disorders Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Urea Cycle Disorders Treatment Drug Revenue
3.4 Global Urea Cycle Disorders Treatment Drug Market Concentration Ratio
3.4.1 Global Urea Cycle Disorders Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urea Cycle Disorders Treatment Drug Revenue in 2024
3.5 Global Key Players of Urea Cycle Disorders Treatment Drug Head office and Area Served
3.6 Global Key Players of Urea Cycle Disorders Treatment Drug, Product and Application
3.7 Global Key Players of Urea Cycle Disorders Treatment Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Urea Cycle Disorders Treatment Drug Breakdown Data by Type
4.1 Global Urea Cycle Disorders Treatment Drug Historic Market Size by Type (2020-2025)
4.2 Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Type (2026-2031)
5 Urea Cycle Disorders Treatment Drug Breakdown Data by Application
5.1 Global Urea Cycle Disorders Treatment Drug Historic Market Size by Application (2020-2025)
5.2 Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Urea Cycle Disorders Treatment Drug Market Size (2020-2031)
6.2 North America Urea Cycle Disorders Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025)
6.4 North America Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Urea Cycle Disorders Treatment Drug Market Size (2020-2031)
7.2 Europe Urea Cycle Disorders Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025)
7.4 Europe Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size (2020-2031)
8.2 Asia-Pacific Urea Cycle Disorders Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Urea Cycle Disorders Treatment Drug Market Size (2020-2031)
9.2 Latin America Urea Cycle Disorders Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025)
9.4 Latin America Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size (2020-2031)
10.2 Middle East & Africa Urea Cycle Disorders Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Horizon Therapeutics Plc
11.1.1 Horizon Therapeutics Plc Company Details
11.1.2 Horizon Therapeutics Plc Business Overview
11.1.3 Horizon Therapeutics Plc Urea Cycle Disorders Treatment Drug Introduction
11.1.4 Horizon Therapeutics Plc Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.1.5 Horizon Therapeutics Plc Recent Development
11.2 Bausch Health Companies Inc.
11.2.1 Bausch Health Companies Inc. Company Details
11.2.2 Bausch Health Companies Inc. Business Overview
11.2.3 Bausch Health Companies Inc. Urea Cycle Disorders Treatment Drug Introduction
11.2.4 Bausch Health Companies Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.2.5 Bausch Health Companies Inc. Recent Development
11.3 Recordati Rare Diseases Inc.
11.3.1 Recordati Rare Diseases Inc. Company Details
11.3.2 Recordati Rare Diseases Inc. Business Overview
11.3.3 Recordati Rare Diseases Inc. Urea Cycle Disorders Treatment Drug Introduction
11.3.4 Recordati Rare Diseases Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.3.5 Recordati Rare Diseases Inc. Recent Development
11.4 Nestle S.A.
11.4.1 Nestle S.A. Company Details
11.4.2 Nestle S.A. Business Overview
11.4.3 Nestle S.A. Urea Cycle Disorders Treatment Drug Introduction
11.4.4 Nestle S.A. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.4.5 Nestle S.A. Recent Development
11.5 Danone S.A.
11.5.1 Danone S.A. Company Details
11.5.2 Danone S.A. Business Overview
11.5.3 Danone S.A. Urea Cycle Disorders Treatment Drug Introduction
11.5.4 Danone S.A. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.5.5 Danone S.A. Recent Development
11.6 Lucane Pharma SA
11.6.1 Lucane Pharma SA Company Details
11.6.2 Lucane Pharma SA Business Overview
11.6.3 Lucane Pharma SA Urea Cycle Disorders Treatment Drug Introduction
11.6.4 Lucane Pharma SA Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.6.5 Lucane Pharma SA Recent Development
11.7 Acer Therapeutics Inc.
11.7.1 Acer Therapeutics Inc. Company Details
11.7.2 Acer Therapeutics Inc. Business Overview
11.7.3 Acer Therapeutics Inc. Urea Cycle Disorders Treatment Drug Introduction
11.7.4 Acer Therapeutics Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.7.5 Acer Therapeutics Inc. Recent Development
11.8 Ultragenyx Pharmaceutical
11.8.1 Ultragenyx Pharmaceutical Company Details
11.8.2 Ultragenyx Pharmaceutical Business Overview
11.8.3 Ultragenyx Pharmaceutical Urea Cycle Disorders Treatment Drug Introduction
11.8.4 Ultragenyx Pharmaceutical Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.8.5 Ultragenyx Pharmaceutical Recent Development
11.9 Aeglea Biotherapeutics, Inc
11.9.1 Aeglea Biotherapeutics, Inc Company Details
11.9.2 Aeglea Biotherapeutics, Inc Business Overview
11.9.3 Aeglea Biotherapeutics, Inc Urea Cycle Disorders Treatment Drug Introduction
11.9.4 Aeglea Biotherapeutics, Inc Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.9.5 Aeglea Biotherapeutics, Inc Recent Development
11.10 Arcturus Therapeutics Holdings Inc.
11.10.1 Arcturus Therapeutics Holdings Inc. Company Details
11.10.2 Arcturus Therapeutics Holdings Inc. Business Overview
11.10.3 Arcturus Therapeutics Holdings Inc. Urea Cycle Disorders Treatment Drug Introduction
11.10.4 Arcturus Therapeutics Holdings Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.10.5 Arcturus Therapeutics Holdings Inc. Recent Development
11.11 Orpharma Pty Ltd.
11.11.1 Orpharma Pty Ltd. Company Details
11.11.2 Orpharma Pty Ltd. Business Overview
11.11.3 Orpharma Pty Ltd. Urea Cycle Disorders Treatment Drug Introduction
11.11.4 Orpharma Pty Ltd. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.11.5 Orpharma Pty Ltd. Recent Development
11.12 Selecta Biosciences, Inc.
11.12.1 Selecta Biosciences, Inc. Company Details
11.12.2 Selecta Biosciences, Inc. Business Overview
11.12.3 Selecta Biosciences, Inc. Urea Cycle Disorders Treatment Drug Introduction
11.12.4 Selecta Biosciences, Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.12.5 Selecta Biosciences, Inc. Recent Development
11.13 Abbott
11.13.1 Abbott Company Details
11.13.2 Abbott Business Overview
11.13.3 Abbott Urea Cycle Disorders Treatment Drug Introduction
11.13.4 Abbott Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.13.5 Abbott Recent Development
11.14 Mead Johnson & Company, LLC
11.14.1 Mead Johnson & Company, LLC Company Details
11.14.2 Mead Johnson & Company, LLC Business Overview
11.14.3 Mead Johnson & Company, LLC Urea Cycle Disorders Treatment Drug Introduction
11.14.4 Mead Johnson & Company, LLC Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.14.5 Mead Johnson & Company, LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Amino Acid Supplements
1.2.3 Sodium Phenylbutyrate
1.2.4 Glycerol Phenylbutyrate
1.2.5 Sodium Benzoate
1.2.6 Others
1.3 Market by Application
1.3.1 Global Urea Cycle Disorders Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Urea Cycle Disorders Treatment Drug Market Perspective (2020-2031)
2.2 Global Urea Cycle Disorders Treatment Drug Growth Trends by Region
2.2.1 Global Urea Cycle Disorders Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Urea Cycle Disorders Treatment Drug Historic Market Size by Region (2020-2025)
2.2.3 Urea Cycle Disorders Treatment Drug Forecasted Market Size by Region (2026-2031)
2.3 Urea Cycle Disorders Treatment Drug Market Dynamics
2.3.1 Urea Cycle Disorders Treatment Drug Industry Trends
2.3.2 Urea Cycle Disorders Treatment Drug Market Drivers
2.3.3 Urea Cycle Disorders Treatment Drug Market Challenges
2.3.4 Urea Cycle Disorders Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Urea Cycle Disorders Treatment Drug Players by Revenue
3.1.1 Global Top Urea Cycle Disorders Treatment Drug Players by Revenue (2020-2025)
3.1.2 Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Players (2020-2025)
3.2 Global Urea Cycle Disorders Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Urea Cycle Disorders Treatment Drug Revenue
3.4 Global Urea Cycle Disorders Treatment Drug Market Concentration Ratio
3.4.1 Global Urea Cycle Disorders Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urea Cycle Disorders Treatment Drug Revenue in 2024
3.5 Global Key Players of Urea Cycle Disorders Treatment Drug Head office and Area Served
3.6 Global Key Players of Urea Cycle Disorders Treatment Drug, Product and Application
3.7 Global Key Players of Urea Cycle Disorders Treatment Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Urea Cycle Disorders Treatment Drug Breakdown Data by Type
4.1 Global Urea Cycle Disorders Treatment Drug Historic Market Size by Type (2020-2025)
4.2 Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Type (2026-2031)
5 Urea Cycle Disorders Treatment Drug Breakdown Data by Application
5.1 Global Urea Cycle Disorders Treatment Drug Historic Market Size by Application (2020-2025)
5.2 Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Urea Cycle Disorders Treatment Drug Market Size (2020-2031)
6.2 North America Urea Cycle Disorders Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025)
6.4 North America Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Urea Cycle Disorders Treatment Drug Market Size (2020-2031)
7.2 Europe Urea Cycle Disorders Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025)
7.4 Europe Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size (2020-2031)
8.2 Asia-Pacific Urea Cycle Disorders Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Urea Cycle Disorders Treatment Drug Market Size (2020-2031)
9.2 Latin America Urea Cycle Disorders Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025)
9.4 Latin America Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size (2020-2031)
10.2 Middle East & Africa Urea Cycle Disorders Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Horizon Therapeutics Plc
11.1.1 Horizon Therapeutics Plc Company Details
11.1.2 Horizon Therapeutics Plc Business Overview
11.1.3 Horizon Therapeutics Plc Urea Cycle Disorders Treatment Drug Introduction
11.1.4 Horizon Therapeutics Plc Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.1.5 Horizon Therapeutics Plc Recent Development
11.2 Bausch Health Companies Inc.
11.2.1 Bausch Health Companies Inc. Company Details
11.2.2 Bausch Health Companies Inc. Business Overview
11.2.3 Bausch Health Companies Inc. Urea Cycle Disorders Treatment Drug Introduction
11.2.4 Bausch Health Companies Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.2.5 Bausch Health Companies Inc. Recent Development
11.3 Recordati Rare Diseases Inc.
11.3.1 Recordati Rare Diseases Inc. Company Details
11.3.2 Recordati Rare Diseases Inc. Business Overview
11.3.3 Recordati Rare Diseases Inc. Urea Cycle Disorders Treatment Drug Introduction
11.3.4 Recordati Rare Diseases Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.3.5 Recordati Rare Diseases Inc. Recent Development
11.4 Nestle S.A.
11.4.1 Nestle S.A. Company Details
11.4.2 Nestle S.A. Business Overview
11.4.3 Nestle S.A. Urea Cycle Disorders Treatment Drug Introduction
11.4.4 Nestle S.A. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.4.5 Nestle S.A. Recent Development
11.5 Danone S.A.
11.5.1 Danone S.A. Company Details
11.5.2 Danone S.A. Business Overview
11.5.3 Danone S.A. Urea Cycle Disorders Treatment Drug Introduction
11.5.4 Danone S.A. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.5.5 Danone S.A. Recent Development
11.6 Lucane Pharma SA
11.6.1 Lucane Pharma SA Company Details
11.6.2 Lucane Pharma SA Business Overview
11.6.3 Lucane Pharma SA Urea Cycle Disorders Treatment Drug Introduction
11.6.4 Lucane Pharma SA Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.6.5 Lucane Pharma SA Recent Development
11.7 Acer Therapeutics Inc.
11.7.1 Acer Therapeutics Inc. Company Details
11.7.2 Acer Therapeutics Inc. Business Overview
11.7.3 Acer Therapeutics Inc. Urea Cycle Disorders Treatment Drug Introduction
11.7.4 Acer Therapeutics Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.7.5 Acer Therapeutics Inc. Recent Development
11.8 Ultragenyx Pharmaceutical
11.8.1 Ultragenyx Pharmaceutical Company Details
11.8.2 Ultragenyx Pharmaceutical Business Overview
11.8.3 Ultragenyx Pharmaceutical Urea Cycle Disorders Treatment Drug Introduction
11.8.4 Ultragenyx Pharmaceutical Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.8.5 Ultragenyx Pharmaceutical Recent Development
11.9 Aeglea Biotherapeutics, Inc
11.9.1 Aeglea Biotherapeutics, Inc Company Details
11.9.2 Aeglea Biotherapeutics, Inc Business Overview
11.9.3 Aeglea Biotherapeutics, Inc Urea Cycle Disorders Treatment Drug Introduction
11.9.4 Aeglea Biotherapeutics, Inc Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.9.5 Aeglea Biotherapeutics, Inc Recent Development
11.10 Arcturus Therapeutics Holdings Inc.
11.10.1 Arcturus Therapeutics Holdings Inc. Company Details
11.10.2 Arcturus Therapeutics Holdings Inc. Business Overview
11.10.3 Arcturus Therapeutics Holdings Inc. Urea Cycle Disorders Treatment Drug Introduction
11.10.4 Arcturus Therapeutics Holdings Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.10.5 Arcturus Therapeutics Holdings Inc. Recent Development
11.11 Orpharma Pty Ltd.
11.11.1 Orpharma Pty Ltd. Company Details
11.11.2 Orpharma Pty Ltd. Business Overview
11.11.3 Orpharma Pty Ltd. Urea Cycle Disorders Treatment Drug Introduction
11.11.4 Orpharma Pty Ltd. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.11.5 Orpharma Pty Ltd. Recent Development
11.12 Selecta Biosciences, Inc.
11.12.1 Selecta Biosciences, Inc. Company Details
11.12.2 Selecta Biosciences, Inc. Business Overview
11.12.3 Selecta Biosciences, Inc. Urea Cycle Disorders Treatment Drug Introduction
11.12.4 Selecta Biosciences, Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.12.5 Selecta Biosciences, Inc. Recent Development
11.13 Abbott
11.13.1 Abbott Company Details
11.13.2 Abbott Business Overview
11.13.3 Abbott Urea Cycle Disorders Treatment Drug Introduction
11.13.4 Abbott Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.13.5 Abbott Recent Development
11.14 Mead Johnson & Company, LLC
11.14.1 Mead Johnson & Company, LLC Company Details
11.14.2 Mead Johnson & Company, LLC Business Overview
11.14.3 Mead Johnson & Company, LLC Urea Cycle Disorders Treatment Drug Introduction
11.14.4 Mead Johnson & Company, LLC Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025)
11.14.5 Mead Johnson & Company, LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Amino Acid Supplements
Table 3. Key Players of Sodium Phenylbutyrate
Table 4. Key Players of Glycerol Phenylbutyrate
Table 5. Key Players of Sodium Benzoate
Table 6. Key Players of Others
Table 7. Global Urea Cycle Disorders Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Urea Cycle Disorders Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Urea Cycle Disorders Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Urea Cycle Disorders Treatment Drug Market Share by Region (2020-2025)
Table 11. Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Urea Cycle Disorders Treatment Drug Market Share by Region (2026-2031)
Table 13. Urea Cycle Disorders Treatment Drug Market Trends
Table 14. Urea Cycle Disorders Treatment Drug Market Drivers
Table 15. Urea Cycle Disorders Treatment Drug Market Challenges
Table 16. Urea Cycle Disorders Treatment Drug Market Restraints
Table 17. Global Urea Cycle Disorders Treatment Drug Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Urea Cycle Disorders Treatment Drug Market Share by Players (2020-2025)
Table 19. Global Top Urea Cycle Disorders Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urea Cycle Disorders Treatment Drug as of 2024)
Table 20. Ranking of Global Top Urea Cycle Disorders Treatment Drug Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Urea Cycle Disorders Treatment Drug Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Urea Cycle Disorders Treatment Drug, Headquarters and Area Served
Table 23. Global Key Players of Urea Cycle Disorders Treatment Drug, Product and Application
Table 24. Global Key Players of Urea Cycle Disorders Treatment Drug, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Urea Cycle Disorders Treatment Drug Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Type (2020-2025)
Table 28. Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Type (2026-2031)
Table 30. Global Urea Cycle Disorders Treatment Drug Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Application (2020-2025)
Table 32. Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Application (2026-2031)
Table 34. North America Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 49. Horizon Therapeutics Plc Company Details
Table 50. Horizon Therapeutics Plc Business Overview
Table 51. Horizon Therapeutics Plc Urea Cycle Disorders Treatment Drug Product
Table 52. Horizon Therapeutics Plc Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 53. Horizon Therapeutics Plc Recent Development
Table 54. Bausch Health Companies Inc. Company Details
Table 55. Bausch Health Companies Inc. Business Overview
Table 56. Bausch Health Companies Inc. Urea Cycle Disorders Treatment Drug Product
Table 57. Bausch Health Companies Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 58. Bausch Health Companies Inc. Recent Development
Table 59. Recordati Rare Diseases Inc. Company Details
Table 60. Recordati Rare Diseases Inc. Business Overview
Table 61. Recordati Rare Diseases Inc. Urea Cycle Disorders Treatment Drug Product
Table 62. Recordati Rare Diseases Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 63. Recordati Rare Diseases Inc. Recent Development
Table 64. Nestle S.A. Company Details
Table 65. Nestle S.A. Business Overview
Table 66. Nestle S.A. Urea Cycle Disorders Treatment Drug Product
Table 67. Nestle S.A. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 68. Nestle S.A. Recent Development
Table 69. Danone S.A. Company Details
Table 70. Danone S.A. Business Overview
Table 71. Danone S.A. Urea Cycle Disorders Treatment Drug Product
Table 72. Danone S.A. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 73. Danone S.A. Recent Development
Table 74. Lucane Pharma SA Company Details
Table 75. Lucane Pharma SA Business Overview
Table 76. Lucane Pharma SA Urea Cycle Disorders Treatment Drug Product
Table 77. Lucane Pharma SA Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 78. Lucane Pharma SA Recent Development
Table 79. Acer Therapeutics Inc. Company Details
Table 80. Acer Therapeutics Inc. Business Overview
Table 81. Acer Therapeutics Inc. Urea Cycle Disorders Treatment Drug Product
Table 82. Acer Therapeutics Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 83. Acer Therapeutics Inc. Recent Development
Table 84. Ultragenyx Pharmaceutical Company Details
Table 85. Ultragenyx Pharmaceutical Business Overview
Table 86. Ultragenyx Pharmaceutical Urea Cycle Disorders Treatment Drug Product
Table 87. Ultragenyx Pharmaceutical Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 88. Ultragenyx Pharmaceutical Recent Development
Table 89. Aeglea Biotherapeutics, Inc Company Details
Table 90. Aeglea Biotherapeutics, Inc Business Overview
Table 91. Aeglea Biotherapeutics, Inc Urea Cycle Disorders Treatment Drug Product
Table 92. Aeglea Biotherapeutics, Inc Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 93. Aeglea Biotherapeutics, Inc Recent Development
Table 94. Arcturus Therapeutics Holdings Inc. Company Details
Table 95. Arcturus Therapeutics Holdings Inc. Business Overview
Table 96. Arcturus Therapeutics Holdings Inc. Urea Cycle Disorders Treatment Drug Product
Table 97. Arcturus Therapeutics Holdings Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 98. Arcturus Therapeutics Holdings Inc. Recent Development
Table 99. Orpharma Pty Ltd. Company Details
Table 100. Orpharma Pty Ltd. Business Overview
Table 101. Orpharma Pty Ltd. Urea Cycle Disorders Treatment Drug Product
Table 102. Orpharma Pty Ltd. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 103. Orpharma Pty Ltd. Recent Development
Table 104. Selecta Biosciences, Inc. Company Details
Table 105. Selecta Biosciences, Inc. Business Overview
Table 106. Selecta Biosciences, Inc. Urea Cycle Disorders Treatment Drug Product
Table 107. Selecta Biosciences, Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 108. Selecta Biosciences, Inc. Recent Development
Table 109. Abbott Company Details
Table 110. Abbott Business Overview
Table 111. Abbott Urea Cycle Disorders Treatment Drug Product
Table 112. Abbott Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 113. Abbott Recent Development
Table 114. Mead Johnson & Company, LLC Company Details
Table 115. Mead Johnson & Company, LLC Business Overview
Table 116. Mead Johnson & Company, LLC Urea Cycle Disorders Treatment Drug Product
Table 117. Mead Johnson & Company, LLC Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 118. Mead Johnson & Company, LLC Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 122. Authors List of This Report
List of Figures
Figure 1. Urea Cycle Disorders Treatment Drug Picture
Figure 2. Global Urea Cycle Disorders Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Urea Cycle Disorders Treatment Drug Market Share by Type: 2024 VS 2031
Figure 4. Amino Acid Supplements Features
Figure 5. Sodium Phenylbutyrate Features
Figure 6. Glycerol Phenylbutyrate Features
Figure 7. Sodium Benzoate Features
Figure 8. Others Features
Figure 9. Global Urea Cycle Disorders Treatment Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Urea Cycle Disorders Treatment Drug Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Urea Cycle Disorders Treatment Drug Report Years Considered
Figure 15. Global Urea Cycle Disorders Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Urea Cycle Disorders Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Urea Cycle Disorders Treatment Drug Market Share by Region: 2024 VS 2031
Figure 18. Global Urea Cycle Disorders Treatment Drug Market Share by Players in 2024
Figure 19. Global Top Urea Cycle Disorders Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urea Cycle Disorders Treatment Drug as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Urea Cycle Disorders Treatment Drug Revenue in 2024
Figure 21. North America Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Urea Cycle Disorders Treatment Drug Market Share by Country (2020-2031)
Figure 23. United States Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Urea Cycle Disorders Treatment Drug Market Share by Country (2020-2031)
Figure 27. Germany Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Share by Region (2020-2031)
Figure 35. China Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Urea Cycle Disorders Treatment Drug Market Share by Country (2020-2031)
Figure 43. Mexico Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Share by Country (2020-2031)
Figure 47. Turkey Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Horizon Therapeutics Plc Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 51. Bausch Health Companies Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 52. Recordati Rare Diseases Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 53. Nestle S.A. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 54. Danone S.A. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 55. Lucane Pharma SA Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 56. Acer Therapeutics Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 57. Ultragenyx Pharmaceutical Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 58. Aeglea Biotherapeutics, Inc Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 59. Arcturus Therapeutics Holdings Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 60. Orpharma Pty Ltd. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 61. Selecta Biosciences, Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 62. Abbott Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 63. Mead Johnson & Company, LLC Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Amino Acid Supplements
Table 3. Key Players of Sodium Phenylbutyrate
Table 4. Key Players of Glycerol Phenylbutyrate
Table 5. Key Players of Sodium Benzoate
Table 6. Key Players of Others
Table 7. Global Urea Cycle Disorders Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Urea Cycle Disorders Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Urea Cycle Disorders Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Urea Cycle Disorders Treatment Drug Market Share by Region (2020-2025)
Table 11. Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Urea Cycle Disorders Treatment Drug Market Share by Region (2026-2031)
Table 13. Urea Cycle Disorders Treatment Drug Market Trends
Table 14. Urea Cycle Disorders Treatment Drug Market Drivers
Table 15. Urea Cycle Disorders Treatment Drug Market Challenges
Table 16. Urea Cycle Disorders Treatment Drug Market Restraints
Table 17. Global Urea Cycle Disorders Treatment Drug Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Urea Cycle Disorders Treatment Drug Market Share by Players (2020-2025)
Table 19. Global Top Urea Cycle Disorders Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urea Cycle Disorders Treatment Drug as of 2024)
Table 20. Ranking of Global Top Urea Cycle Disorders Treatment Drug Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Urea Cycle Disorders Treatment Drug Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Urea Cycle Disorders Treatment Drug, Headquarters and Area Served
Table 23. Global Key Players of Urea Cycle Disorders Treatment Drug, Product and Application
Table 24. Global Key Players of Urea Cycle Disorders Treatment Drug, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Urea Cycle Disorders Treatment Drug Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Type (2020-2025)
Table 28. Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Type (2026-2031)
Table 30. Global Urea Cycle Disorders Treatment Drug Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Application (2020-2025)
Table 32. Global Urea Cycle Disorders Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Application (2026-2031)
Table 34. North America Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 49. Horizon Therapeutics Plc Company Details
Table 50. Horizon Therapeutics Plc Business Overview
Table 51. Horizon Therapeutics Plc Urea Cycle Disorders Treatment Drug Product
Table 52. Horizon Therapeutics Plc Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 53. Horizon Therapeutics Plc Recent Development
Table 54. Bausch Health Companies Inc. Company Details
Table 55. Bausch Health Companies Inc. Business Overview
Table 56. Bausch Health Companies Inc. Urea Cycle Disorders Treatment Drug Product
Table 57. Bausch Health Companies Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 58. Bausch Health Companies Inc. Recent Development
Table 59. Recordati Rare Diseases Inc. Company Details
Table 60. Recordati Rare Diseases Inc. Business Overview
Table 61. Recordati Rare Diseases Inc. Urea Cycle Disorders Treatment Drug Product
Table 62. Recordati Rare Diseases Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 63. Recordati Rare Diseases Inc. Recent Development
Table 64. Nestle S.A. Company Details
Table 65. Nestle S.A. Business Overview
Table 66. Nestle S.A. Urea Cycle Disorders Treatment Drug Product
Table 67. Nestle S.A. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 68. Nestle S.A. Recent Development
Table 69. Danone S.A. Company Details
Table 70. Danone S.A. Business Overview
Table 71. Danone S.A. Urea Cycle Disorders Treatment Drug Product
Table 72. Danone S.A. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 73. Danone S.A. Recent Development
Table 74. Lucane Pharma SA Company Details
Table 75. Lucane Pharma SA Business Overview
Table 76. Lucane Pharma SA Urea Cycle Disorders Treatment Drug Product
Table 77. Lucane Pharma SA Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 78. Lucane Pharma SA Recent Development
Table 79. Acer Therapeutics Inc. Company Details
Table 80. Acer Therapeutics Inc. Business Overview
Table 81. Acer Therapeutics Inc. Urea Cycle Disorders Treatment Drug Product
Table 82. Acer Therapeutics Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 83. Acer Therapeutics Inc. Recent Development
Table 84. Ultragenyx Pharmaceutical Company Details
Table 85. Ultragenyx Pharmaceutical Business Overview
Table 86. Ultragenyx Pharmaceutical Urea Cycle Disorders Treatment Drug Product
Table 87. Ultragenyx Pharmaceutical Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 88. Ultragenyx Pharmaceutical Recent Development
Table 89. Aeglea Biotherapeutics, Inc Company Details
Table 90. Aeglea Biotherapeutics, Inc Business Overview
Table 91. Aeglea Biotherapeutics, Inc Urea Cycle Disorders Treatment Drug Product
Table 92. Aeglea Biotherapeutics, Inc Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 93. Aeglea Biotherapeutics, Inc Recent Development
Table 94. Arcturus Therapeutics Holdings Inc. Company Details
Table 95. Arcturus Therapeutics Holdings Inc. Business Overview
Table 96. Arcturus Therapeutics Holdings Inc. Urea Cycle Disorders Treatment Drug Product
Table 97. Arcturus Therapeutics Holdings Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 98. Arcturus Therapeutics Holdings Inc. Recent Development
Table 99. Orpharma Pty Ltd. Company Details
Table 100. Orpharma Pty Ltd. Business Overview
Table 101. Orpharma Pty Ltd. Urea Cycle Disorders Treatment Drug Product
Table 102. Orpharma Pty Ltd. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 103. Orpharma Pty Ltd. Recent Development
Table 104. Selecta Biosciences, Inc. Company Details
Table 105. Selecta Biosciences, Inc. Business Overview
Table 106. Selecta Biosciences, Inc. Urea Cycle Disorders Treatment Drug Product
Table 107. Selecta Biosciences, Inc. Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 108. Selecta Biosciences, Inc. Recent Development
Table 109. Abbott Company Details
Table 110. Abbott Business Overview
Table 111. Abbott Urea Cycle Disorders Treatment Drug Product
Table 112. Abbott Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 113. Abbott Recent Development
Table 114. Mead Johnson & Company, LLC Company Details
Table 115. Mead Johnson & Company, LLC Business Overview
Table 116. Mead Johnson & Company, LLC Urea Cycle Disorders Treatment Drug Product
Table 117. Mead Johnson & Company, LLC Revenue in Urea Cycle Disorders Treatment Drug Business (2020-2025) & (US$ Million)
Table 118. Mead Johnson & Company, LLC Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 122. Authors List of This Report
List of Figures
Figure 1. Urea Cycle Disorders Treatment Drug Picture
Figure 2. Global Urea Cycle Disorders Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Urea Cycle Disorders Treatment Drug Market Share by Type: 2024 VS 2031
Figure 4. Amino Acid Supplements Features
Figure 5. Sodium Phenylbutyrate Features
Figure 6. Glycerol Phenylbutyrate Features
Figure 7. Sodium Benzoate Features
Figure 8. Others Features
Figure 9. Global Urea Cycle Disorders Treatment Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Urea Cycle Disorders Treatment Drug Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Urea Cycle Disorders Treatment Drug Report Years Considered
Figure 15. Global Urea Cycle Disorders Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Urea Cycle Disorders Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Urea Cycle Disorders Treatment Drug Market Share by Region: 2024 VS 2031
Figure 18. Global Urea Cycle Disorders Treatment Drug Market Share by Players in 2024
Figure 19. Global Top Urea Cycle Disorders Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urea Cycle Disorders Treatment Drug as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Urea Cycle Disorders Treatment Drug Revenue in 2024
Figure 21. North America Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Urea Cycle Disorders Treatment Drug Market Share by Country (2020-2031)
Figure 23. United States Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Urea Cycle Disorders Treatment Drug Market Share by Country (2020-2031)
Figure 27. Germany Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Urea Cycle Disorders Treatment Drug Market Share by Region (2020-2031)
Figure 35. China Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Urea Cycle Disorders Treatment Drug Market Share by Country (2020-2031)
Figure 43. Mexico Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Urea Cycle Disorders Treatment Drug Market Share by Country (2020-2031)
Figure 47. Turkey Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Urea Cycle Disorders Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Horizon Therapeutics Plc Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 51. Bausch Health Companies Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 52. Recordati Rare Diseases Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 53. Nestle S.A. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 54. Danone S.A. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 55. Lucane Pharma SA Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 56. Acer Therapeutics Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 57. Ultragenyx Pharmaceutical Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 58. Aeglea Biotherapeutics, Inc Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 59. Arcturus Therapeutics Holdings Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 60. Orpharma Pty Ltd. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 61. Selecta Biosciences, Inc. Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 62. Abbott Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 63. Mead Johnson & Company, LLC Revenue Growth Rate in Urea Cycle Disorders Treatment Drug Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232